JP Morgan Chase’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-251,393
Closed -$33.2M 6240
2018
Q4
$33.2M Buy
251,393
+63,194
+34% +$8.1M 0.01% 1126
2018
Q3
$25.1M Buy
188,199
+65,802
+54% +$9.86M ﹤0.01% 1484
2018
Q2
$19.5M Buy
122,397
+76,229
+165% +$11.3M ﹤0.01% 1602
2018
Q1
$6.6M Buy
46,168
+4,764
+12% +$651K ﹤0.01% 2343
2017
Q4
$5.51M Sell
41,404
-101,786
-71% -$13M ﹤0.01% 2612
2017
Q3
$17.7M Buy
143,190
+142,321
+16,378% +$19.6M ﹤0.01% 1591
2017
Q2
$123K Sell
869
-1,679
-66% -$210K ﹤0.01% 4111
2017
Q1
$288K Buy
2,548
+601
+31% +$70K ﹤0.01% 3933
2016
Q4
$205K Buy
1,947
+1,463
+302% +$157K ﹤0.01% 4177
2016
Q3
$61K Sell
484
-100,203
-100% -$12.7M ﹤0.01% 3990
2016
Q2
$13.9M Buy
100,687
+15,853
+19% +$2.1M ﹤0.01% 1644
2016
Q1
$11.8M Sell
84,834
-1,067
-1% -$146K ﹤0.01% 1681
2015
Q4
$13.8M Sell
85,901
-7,270
-8% -$1.12M ﹤0.01% 1590
2015
Q3
$12.4M Buy
93,171
+26,772
+40% +$3.49M ﹤0.01% 1595
2015
Q2
$7.61M Buy
66,399
+38,258
+136% +$4.57M ﹤0.01% 2120
2015
Q1
$3.36M Buy
28,141
+22,424
+392% +$2.99M ﹤0.01% 2597
2014
Q4
$833K Sell
5,717
-221,731
-97% -$27.8M ﹤0.01% 3450
2014
Q3
$30M Sell
227,448
-78,573
-26% -$10.3M 0.01% 1202
2014
Q2
$38.3M Sell
306,021
-228,690
-43% -$29.5M 0.01% 987
2014
Q1
$85.7M Buy
534,711
+257,624
+93% +$42.4M 0.02% 601
2013
Q4
$37.3M Buy
277,087
+187,045
+208% +$24M 0.01% 963
2013
Q3
$9.78M Sell
90,042
-93,676
-51% -$10.1M ﹤0.01% 1772
2013
Q2
$15.6M Buy
+183,718
New +$16.4M 0.01% 1401

JP Morgan Chase's ATHN Position: Q1 2019 in Review

JP Morgan Chase sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 251,393 shares — an estimated $33.2M sold.

JP Morgan Chase first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $85.7M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • JP Morgan Chase reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Chase sold 251,393 Athenahealth, Inc. shares in Q1 2019, an estimated $33.2M.
  • JP Morgan Chase first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
  • JP Morgan Chase's Athenahealth, Inc. position peaked at $85.7M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.